According to Mergermarket’s Leauge Tables, in the first quarter of 2020, Bär & Karrer is the first Swiss law firm per number of deals. Looking at the tables by value, Lenz & Stahelin tops the ranking.
Working from home regularly may create tax liability for both the employer and employee as well as liability for social security contributions.
Elmar Büth, General Counsel Supply Chain & Healthcare Business EMEA at 3M, unveils to Legalcommunity.ch how Covid-19 outbreak has changed his work, what are the main legal implications and how this crisis could shape
The worldwide supplier of high performance sensor solutions ams completed a capital increase by way of a rights offering raising gross proceeds of approximately CHF 1.75 billion.
Switzerland-based private equity firm Ufenau Capital Partners has acquired Germany-based IKOR, which advises companies on digitalization processes, including the use and implementation of SAP and Guidewire software.
In late March 2020, Credit Suisse Group launched the issuance of Usd 3 bn 4.194% fixed rate/floating rate senior callable notes due 2031 under its Us Senior Debt Program and the issuance of Eur 2 bn 3.250% fixed rate reset
Schellenberg Wittmer is contributing cybersecurity support in legal matters to the Pandemic Taskforce of the Information Security Society Switzerland (ISSS), Switzerland's largest association focusing on cybersecurity.
Deal & transactions
MCAM Symalit acquires recycling activities from Minger Kunststofftechnik: the advisor
Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high performance materials, had announced in February to have entered into an agreement for the acquisition of all the recycling activities of Minger Kunststofftechnik through
According to the results of a survey released by the Association of Corporate Counsel (ACC), a vast majority of general counsel (68%) said their legal departments were prepared for the transition to working from home during
Relief Therapeutics Holding announces the closing of the binding Share Exchange Agreement for the acquisition by Sonnet BioTherapeutics, now a subsidiary of Sonnet BioTherapeutics Holdings
